High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors

Vox Sanguinis

Volumn 102, Issue 3, 2012, Pages 234-242

  Jungbauer, C ^a   Hobel, C M ^a   Schwartz, D W M ^b   Mayr, W R ^a,b  

^a Austrian Red Cross   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blood groups; Genotyping; High throughput testing; Immunohematology; Molecular testing; RBC antigens and antibodies

Indexed keywords

ERYTHROCYTE ANTIGEN;

ALLELE; ALLOIMMUNIZATION; ARTICLE; BLOOD COMPATIBILITY; BLOOD DONOR; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP MNSS SYSTEM; CONTROLLED STUDY; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING;

ALLELES; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; POLYMERASE CHAIN REACTION;

EID: 84858276939     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01542.x     Document Type: Article

References (40)

1. Hoeltge GA, Domen RE, Rybicki LA, et al.: Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159, 262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119:42-45
2. Winters JL, Pineda AA, Gorden LD, et al.: RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001; 41:1413-1420
3. Walker RH, Lin DT, Hartrick MB: Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989; 113:254-261
4. Spielmann W, Seidl S: Prevalence of irregular red cell antibodies and their significance in blood transfusion and antenatal care. Vox Sang 1974; 26:551-559
5. Heddle NM, Klama L, Frassetto R, et al.: A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993; 33:217-220
6. Aygun B, Padmanabhan S, Paley C, et al.: Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42:37-43
7. Singer ST, Wu V, Mignacca R, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 2000; 96:3369-3373
8. Castro O, Sandler SG, Houston-Yu P, et al.: Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42:684-690
9. Schonewille H, de Vries RR, Brand A: Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009; 49:453-457
10. Seltsam A, Wagner FF, Salama A, et al.: Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003; 43:1563-1566
11. Denomme GA, Van Oene M: High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005; 45:660-666
12. Montpetit A, Phillips MS, Mongrain I, et al.: High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006; 46:841-848
13. Hashmi G, Shariff T, Seul M, et al.: A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005; 45:680-688
14. Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, et al.: Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005; 45:667-679
15. Avent ND, Martinez A, Flegel WA, et al.: The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007; 47:40S-46S
16. Polin H, Danzer M, Proll J, et al.: Introduction of a real-time-based blood-group genotyping approach. Vox Sang 2008; 95:125-130
17. Drago F, Karpasitou K, Poli F: Microarray beads for identifying blood group single nucleotide polymorphisms. Transfus Med Hemother 2009; 36:157-160
18. Avent ND, Martinez A, Flegel WA, et al.: The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009; 36:162-167
19. Siebert PD, Fukuda M: Molecular cloning of a human glycophorin B cDNA: nucleotide sequence and genomic relationship to glycophorin A. Proc Natl Acad Sci USA 1987; 84:6735-6739
20. Kudo S, Onda M, Fukuda M: Characterization of glycophorin A transcripts: control by the common erythroid-specific promoter and alternative usage of different polyadenylation signals. J Biochem 1994; 116:183-192
21. Parsons SF, Mallinson G, Holmes CH, et al.: The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 1995; 92:5496-5500
22. Lee S, Wu X, Reid M, et al.: Molecular basis of the Kell (K1) phenotype. Blood 1995; 85:912-916
23. Lee S: Molecular basis of Kell blood group phenotypes. Vox Sang 1997; 73:1-11
24. Chaudhuri A, Polyakova J, Zbrzezna V, et al.: Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 1993; 90:10793-10797
25. Olsson ML, Smythe JS, Hansson C, et al.: The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998; 103:1184-1191
26. Tournamille C, Le Van Kim C, Gane P, et al.: Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998; 92:2147-2156
27. Tournamille C, Colin Y, Cartron JP, et al.: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10:224-228
28. Li J, Iwamoto S, Sugimoto N, et al.: Dinucleotide repeat in the 3' flanking region provides a clue to the molecular evolution of the Duffy gene. Hum Genet 1997; 99:573-577
29. Olives B, Merriman M, Bailly P, et al.: The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet 1997; 6:1017-1020
30. Bruce LJ, Anstee DJ, Spring FA, et al.: Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854-->Leu. J Biol Chem 1994; 269:16155-16158
31. Bruce LJ, Ring SM, Anstee DJ, et al.: Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood 1995; 85:541-547
32. Bartels CF, Zelinski T, Lockridge O: Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet 1993; 52:928-936
33. Gubin AN, Njoroge JM, Wojda U, et al.: Identification of the dombrock blood group glycoprotein as a polymorphic member of the ADPribosyltransferase gene family. Blood 2000; 96:2621-2627
34. Smith BL, Preston GM, Spring FA, et al.: Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994; 94:1043-1049
35. Telen MJ, Udani M, Washington MK, et al.: A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. J Biol Chem 1996; 271:7147-7153
36. Blumenfeld OO, Patnaik SK: Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004; 23:8-16
37. Nance SJ: The utilization of rare blood donors. ISBT Science Series 2007; 2:59-63
38. Karpasitou K, Drago F, Crespiatico L, et al.: Blood group genotyping for Jk(a)/Jk(b), Fy(a)/Fy(b), S/s, K/k, Kp(a)/Kp(b), Js(a)/Js(b), Co(a)/Co(b), and Lu(a)/Lu(b) with microarray beads. Transfusion 2008; 48:505-512
39. Perreault J, Lavoie J, Painchaud P, et al.: Set-up and routine use of a database of 10, 555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang 2009; 97:61-68
40. Daniels G, van der Schoot CE, Gassner C, et al.: Report of the third international workshop on molecular blood group genotyping. Vox Sang 2009; 96:337-343